Mycophenolate Sodium for Children with Frequently Relapsing or Steroid Dependent Nephrotic Syndrome

被引:3
|
作者
Kapoor, Kanika [1 ,2 ]
Saha, Abhijeet [1 ,2 ]
Kaur, Manpreet [1 ,2 ]
Dubey, Nand Kishore [1 ,2 ]
Upadhyay, Ashish Datt [3 ]
机构
[1] PGIMER, Dept Pediat, New Delhi, India
[2] Dr Ram Manohar Lohia Hosp, New Delhi, India
[3] AIIMS, Dept Biostat, New Delhi, India
关键词
Minimal change disease; Proteinuria; Refractory; Treatment; MOFETIL; PREDNISOLONE;
D O I
10.1007/s13312-017-1156-5
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
In this retrospective study, patients with idiopathic frequentlyrelapsing nephrotic syndrome (FRNS) (n = 27) and steroid dependent nephrotic syndrome (SDNS) (n = 13) who received enteric coated mycophenolate sodium (ECMS) for at least 6 months, were included for analysis. Primary outcome was response to ECMS, which was defined as complete if there were no relapses, partial response if there was 1 relapse and no response if there were 2 or more relapses within 6 months of initiation. The mean (SD) dose of ECMS was 985.24 (190.82) mg/m(2)/day. Thirty patients(75%) had complete response, eight (20%) had partial and two (5%) patients did not respond at 6 months. ECMS seems to be a safe and effective as steroid sparing agent in children with FRNS/SDNS.
引用
收藏
页码:885 / 886
页数:2
相关论文
共 50 条
  • [21] Cyclophosphamide and rituximab in frequently relapsing/steroid-dependent nephrotic syndrome
    Webb, Hazel
    Jaureguiberry, Graciana
    Dufek, Stephanie
    Tullus, Kjell
    Bockenhauer, Detlef
    PEDIATRIC NEPHROLOGY, 2016, 31 (04) : 589 - 594
  • [22] Rituximab in Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome
    Ruggenenti, Piero
    Ruggiero, Barbara
    Cravedi, Paolo
    Vivarelli, Marina
    Massella, Laura
    Marasa, Maddalena
    Chianca, Antonietta
    Rubis, Nadia
    Ene-Iordache, Bogdan
    Rudnicki, Michael
    Pollastro, Rosa Maria
    Capasso, Giovambattista
    Pisani, Antonio
    Pennesi, Marco
    Emma, Francesco
    Remuzzi, Giuseppe
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2014, 25 (04): : 850 - 863
  • [23] Experience with levamisole in frequently relapsing, steroid-dependent nephrotic syndrome
    Al-Saran, K
    Mirza, K
    Al-Ghanam, G
    Abdelkarim, M
    PEDIATRIC NEPHROLOGY, 2006, 21 (02) : 201 - 205
  • [24] Cyclophosphamide and rituximab in frequently relapsing/steroid-dependent nephrotic syndrome
    Hazel Webb
    Graciana Jaureguiberry
    Stephanie Dufek
    Kjell Tullus
    Detlef Bockenhauer
    Pediatric Nephrology, 2016, 31 : 589 - 594
  • [25] SPONTANEOUS REMISSIONS IN FREQUENTLY RELAPSING AND STEROID DEPENDENT IDIOPATHIC NEPHROTIC SYNDROME
    WINGEN, AM
    MULLERWIEFEL, DE
    SCHARER, K
    CLINICAL NEPHROLOGY, 1985, 23 (01) : 35 - 40
  • [26] Triggers of relapse in steroid-dependent and frequently relapsing nephrotic syndrome
    Takahashi, Shori
    Wada, Naohiro
    Murakami, Hitohiko
    Funaki, Satoshi
    Inagaki, Tetsuji
    Harada, Kensuke
    Nagata, Michio
    PEDIATRIC NEPHROLOGY, 2007, 22 (02) : 232 - 236
  • [27] Levamisole in Frequently-relapsing and Steroid-dependent Nephrotic Syndrome
    Samuel, Evangeline Mary Kiruba
    Krishnamurthy, Sriram
    Bhanudeep, Singanamalla
    Muske, Sravani
    INDIAN PEDIATRICS, 2017, 54 (10) : 831 - 834
  • [28] SPONTANEOUS REMISSION IN FREQUENTLY RELAPSING AND STEROID-DEPENDENT NEPHROTIC SYNDROME
    WINGEN, AM
    OERTEL, PJ
    MULLERWIEFEL, DE
    SCHARER, K
    INTERNATIONAL JOURNAL OF PEDIATRIC NEPHROLOGY, 1982, 3 (02): : 148 - 148
  • [29] Levamisole in frequently-relapsing and steroid-dependent nephrotic syndrome
    Evangeline Mary Kiruba Samuel
    Sriram Krishnamurthy
    Singanamalla Bhanudeep
    Sravani Muske
    Indian Pediatrics, 2017, 54 : 831 - 834
  • [30] Frequently relapsing nephrotic syndrome: treatment with mycophenolate mofetil
    Gellermann, J
    Querfeld, U
    PEDIATRIC NEPHROLOGY, 2004, 19 (01) : 101 - 104